CN113925129A - 一种谷物冲调粉及其制备方法 - Google Patents
一种谷物冲调粉及其制备方法 Download PDFInfo
- Publication number
- CN113925129A CN113925129A CN202110965978.1A CN202110965978A CN113925129A CN 113925129 A CN113925129 A CN 113925129A CN 202110965978 A CN202110965978 A CN 202110965978A CN 113925129 A CN113925129 A CN 113925129A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- calcium alginate
- cereal
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 102
- 235000013339 cereals Nutrition 0.000 title claims abstract description 59
- 238000002156 mixing Methods 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 110
- 241000894006 Bacteria Species 0.000 claims abstract description 65
- 239000004310 lactic acid Substances 0.000 claims abstract description 55
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 55
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 21
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 13
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims abstract description 10
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 9
- 229920001202 Inulin Polymers 0.000 claims abstract description 8
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 8
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 8
- 235000013365 dairy product Nutrition 0.000 claims abstract description 8
- 229940029339 inulin Drugs 0.000 claims abstract description 8
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 8
- 238000004806 packaging method and process Methods 0.000 claims abstract description 7
- 239000003094 microcapsule Substances 0.000 claims description 36
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 23
- 239000011575 calcium Substances 0.000 claims description 23
- 229910052791 calcium Inorganic materials 0.000 claims description 23
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 claims description 20
- 235000010410 calcium alginate Nutrition 0.000 claims description 20
- 239000000648 calcium alginate Substances 0.000 claims description 20
- 229960002681 calcium alginate Drugs 0.000 claims description 20
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 20
- 229920001661 Chitosan Polymers 0.000 claims description 17
- 241000234295 Musa Species 0.000 claims description 9
- 241000186660 Lactobacillus Species 0.000 claims description 8
- 229940039696 lactobacillus Drugs 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 240000007472 Leucaena leucocephala Species 0.000 claims description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims description 2
- 239000011162 core material Substances 0.000 claims description 2
- 230000029087 digestion Effects 0.000 abstract description 19
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 17
- 230000001105 regulatory effect Effects 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 240000005561 Musa balbisiana Species 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 description 47
- 239000002775 capsule Substances 0.000 description 17
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 239000012530 fluid Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 210000004051 gastric juice Anatomy 0.000 description 9
- 206010000060 Abdominal distension Diseases 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000013312 flour Nutrition 0.000 description 6
- 239000006041 probiotic Substances 0.000 description 5
- 235000018291 probiotics Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000205 acacia gum Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 244000293889 Bombax malabaricum Species 0.000 description 1
- 235000004480 Bombax malabaricum Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 235000020144 banana milk drink Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000005027 intestinal barrier Anatomy 0.000 description 1
- 230000007358 intestinal barrier function Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000009270 zilongjin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本申请涉及冲饮食品技术领域,具体公开了一种谷物冲调粉及其制备方法。一种谷物冲调粉,由包括以下重量份的原料制备而成:豌豆粉15‑25份、低聚异麦芽糖14.5‑15.5份、植脂末5‑20份、香蕉粉1‑3份、菊粉1‑5份、麦芽糊精0.5‑1.5份、乳酸菌粉0.7‑0.85份、柠檬酸0.008‑0.012份、香精0.008‑0.012份。其制备方法为将原料混合均匀后,按规格进行包装。本申请的谷物冲调粉具有提高对人体肠道的调节作用,促进消化优点。
Description
技术领域
本申请涉及冲饮食品技术领域,更具体地说,它涉及一种谷物冲调粉及其制备方法。
背景技术
随着社会的进步以及经济水平的提升,人们的生活水平得到了极大的提高,在食品结构中,粮食投入比重下降,而肉类以及碳水类化合物的比重有所提升,不利于均衡膳食,在快节奏的生活中,人们需要一种简单快捷的补充“粮食”的方法,谷物冲调粉应运而生。
谷物冲调粉是用谷物粉、调味剂、甜味剂、天然香料等以一定比例调配而成的可冲饮食用的一种速食产品。为了调节肠道菌群,促进消化,有的产品中会添加一些益生菌。
正对上述相关技术,发明人发现现有的含益生菌的谷物冲调粉在调节肠道菌群,促进消化方面的效果较差,这可能是因为益生菌无法在高温和胃酸的环境下存活继而活着到达肠道,使得到达肠道的有效调节物质较少,从而效果较差。
发明内容
为了提高谷物冲调粉对人体肠道的调节作用,促进消化,本申请提供一种谷物冲调粉及其制备方法。
第一方面,本申请提供一种谷物冲调粉,采用如下的技术方案:
一种谷物冲调粉,由包括以下重量份的原料制备而成:豌豆粉15-25份、低聚异麦芽糖14.5-15.5份、植脂末5-20份、香蕉粉1-3份、菊粉1-5份、麦芽糊精0.5-1.5份、乳酸菌粉0.7-0.85份、柠檬酸0.008-0.012份、香精0.008-0.012份。
通过采用上述技术方案,豌豆粉与植脂末作为主要成分,主要用来产生饱腹感,低聚麦芽糖不会被胃酶消化,而会直接进入到肠道中,低聚异麦芽糖能促进肠道内双歧杆菌增殖,抑制肠道有害菌及腐败物质形成,增加维生素含量,提高机体免疫力,同时低聚麦芽糖还可以被到达肠道中的乳酸菌利用,促进乳酸菌在肠道内繁殖,调节肠道内的菌群环境,抑制肠道内腐生菌的滋生,在香蕉粉的协同作用下,遏制因食物发酵而致有毒气体及有毒物质在肠道内的生成,加速有害物质排出体外,增加排泄次数和排泄分量,从而减少腹部胀痛和肠道胀气,同时,还可以促进人体对食物中的蛋白质的消化和吸收。另外,肠内其它有害菌则不能利用低聚异麦芽糖,从而能抑制有害菌生长,促使肠道内微生态向良性循环调整。
优选的,一种谷物冲调粉,由包括以下重量份的原料制备而成:豌豆粉16-20份、低聚异麦芽糖15-15.4份、植脂末8-15份、香蕉粉1.5-2.5份、菊粉2-4份、麦芽糊精0.8-1.2份、乳酸菌粉0.75-0.82份、柠檬酸0.009-0.011份、香精0.009-0.011份。
通过采用上述技术方案,进一步优化原料间的配比,从而提升谷物冲调粉的整体性能。
优选的,所述谷物冲调粉还包括重量份为0.3-0.5的三丁酸甘油酯。
通过采用上述技术方案,乳酸菌可迅速在肠黏膜上定植,产生胞外糖苷酶等活性物质及大量醋酸和乳酸等酸性物质,降低肠道pH值,抑制致病菌增殖。三丁酸甘油酯可促进肠黏膜的发育成熟,形成肠道屏障,还可通过调节肠道pH值优化菌群结构。乳酸菌、三丁酸甘油酯均会降低肠道菌群丰度,三丁酸甘油酯水解通过氢离子沉积降低消化道的pH值,乳酸菌分解产生的乳酸,使肠道环境过酸,从而抑制部分细菌增殖,乳酸菌与三丁酸甘油酯对肠道pH值的降低起协同作用,有利于对肠道菌群的调节以及促进消化。
优选的,以所述乳酸菌粉为芯材,以海藻酸钙为壁材,制备海藻酸钙微胶囊,将乳酸菌粉以海藻酸钙微胶囊的形式添加。
通过采用上述技术方案,胃液为强酸环境,乳酸菌在胃液中容易被分解,存活率低,从而导致到达肠道中的活菌数降低,而将海藻酸钙包裹在乳酸菌粉外,将乳酸菌粉以微胶囊的形式通过胃液,胶囊壁对乳酸菌起到保护作用,海藻酸钙微胶囊在低pH值环境下维持稳定的结构,随着pH值的升高,海藻酸钙微胶囊的结构稳定性逐渐降低,即海藻酸钙在胃液中稳定性高,可以对乳酸菌起到有效保护,而达到肠液后,海藻酸钙结构稳定性降低,将乳酸菌释放出来,发挥乳酸菌的作用,有利于提高对肠道菌群的调节作用。
优选的,在所述海藻酸钙微胶囊外包裹壳聚糖,制备海藻酸钙-壳聚糖微胶囊,将乳酸菌粉以海藻酸钙-壳聚糖微胶囊的形式添加。
通过采用上述技术方案,对乳酸菌进行双层保护,进一步提高在胃液中对乳酸菌的保护作用,另外还可以延缓胶囊的崩解时间,使得胶囊中乳酸菌在肠道内缓慢释放,有助于微胶囊中乳酸菌到达肠道远端,发挥其调节肠道菌群、助消化的作用。
优选的,在所述海藻酸钙-壳聚糖微胶囊包裹阿拉伯胶,制备海藻酸钙-壳聚糖-阿拉伯胶微胶囊,将乳酸菌粉以海藻酸钙-壳聚糖-阿拉伯胶微胶囊的形式添加。
通过采用上述技术方案,对乳酸菌进行三层保护,进一步提高在胃液中对乳酸菌的保护作用,并进一步使得胶囊中乳酸菌在肠道内缓慢释放,有助于微胶囊中乳酸菌到达肠道远端,发挥其调节肠道菌群、助消化的作用。
优选的,所述海藻酸钙-壳聚糖-阿拉伯胶微胶囊的粒径为400-450μm。
通过采用上述技术方案,此粒径范围内的胶囊可以起到对乳酸菌更好的运输效果,使得乳酸菌更好的达到肠液中发挥作用。
第二方面,本申请提供一种谷物冲调粉的制备方法,采用如下的技术方案:
一种谷物冲调粉的制备方法,包括以下步骤:
粉碎;将粒径大于60目的原料粉碎为60-80目;
混料:将原料按重量份混合均匀;
装包:将混合均匀的原料的按规格进行包装。
优选的,混料时间大于等于20min。
通过采用上述技术方案,使得原料充分混合,提高谷物冲调粉的均匀性,提高食用口感。
综上所述,本申请具有以下有益效果:
1、本申请采用低聚异麦芽糖与乳酸菌粉配合使用,低于异麦芽糖与乳酸菌粉在肠液中发挥协同作用,提高对肠道内菌群的调节效果,促进消化,饮用本申请的谷物冲调粉后,在缓解食积气滞症状方面的有效率达到43.33%-76.67%,在缓解腹胀便秘症状方面的有效率达到46.67%-80.00%。
2、本申请中优选添加三丁酸甘油酯,与乳酸菌协同作用,进一步提高谷物冲调粉调节肠道菌群、助消化的功效。
3、本申请将乳酸菌粉以微胶囊的形式添加,降低胃液对乳酸菌的破坏作用,使得到达肠液中的活菌数提高,进一步提高谷物冲调粉调节肠道菌群、助消化的功效。
具体实施方式
以下结合实施例对本申请作进一步详细说明。
原料和中间体的制备例
原料
豌豆粉,购自江山市五谷庄园食品有限公司;
低聚异麦芽糖,购自山东百龙创园生物科技股份有限公司;
植脂末,购自山东天骄生物技术有限公司;
香蕉粉,购自天津锦橙生物科技有限公司;
菊粉,为智力菊粉;
麦芽糊精,购自山东西王糖业有限公司;
乳酸菌粉,购自上海昊岳食品科技有限公司;
柠檬酸,购自潍坊英轩实业有限公司;
香精为香蕉牛奶粉末香精,购自泛亚(武汉)食品科技有限公司;
三丁酸甘油酯,购自四川都康生物科技有限公司;
海藻酸钙,购自西安浩天生物工程有限公司;
壳聚糖、阿拉伯胶,购自上海阿拉丁生化科技股份有限公司,脱乙酰度≥95%,粘度100-200mPa.s。
制备例
制备例1
海藻酸钙微胶囊的制备方法为:
将1kg乳酸菌粉与10L质量百分数为1.5%的海藻酸钠溶液混合均匀,将混合液加入单分散液滴发生器中,调节系统载气压力为0.8kg/cm2,脉冲发生器频率为10kHz,分散风流量为9L/min,将混合液从150μm的喷嘴喷出形成分散液滴,液滴落入质量百分数为2%的CaCl2溶液中固化30min,过滤洗涤得到海藻酸钙微胶囊。
制备例2
海藻酸钙-壳聚糖微胶囊的制备方法为:
将壳聚糖溶于0.1mol/L乙酸溶液中,制备用质量百分浓度为0.5%的壳聚糖溶液,然后用1mol/LNaOH将壳聚糖溶液调节pH值至5.8,将制备例1得到的海藻酸钙微胶囊浸于壳聚糖溶液中,磁力搅拌30min进行涂层,得到海藻酸钙-壳聚糖胶囊。
制备例3
海藻酸钙-壳聚糖-阿拉伯胶微胶囊的制备方法:
将制备例2得到的海藻酸钙-壳聚糖胶囊浸于质量浓度为1%的阿拉伯胶溶液中,搅拌涂覆30min,过滤回收得到海藻酸钙-壳聚糖-阿拉伯胶胶囊,海藻酸钙-壳聚糖-阿拉伯胶胶囊为400-450μm。
制备例4
与制备例3不同的是,按照制备例1的制备方法,以100μm的喷嘴制备海藻酸钙微胶囊,然后再依次按照制备例2、制备例3的方法制备海藻酸钙-壳聚糖-阿拉伯胶胶囊,海藻酸钙-壳聚糖-阿拉伯胶胶囊为350-390μm。
制备例5
与制备例3不同的是,按照制备例1的制备方法,以200μm的喷嘴制备海藻酸钙微胶囊,然后再依次按照制备例2、制备例3的方法制备海藻酸钙-壳聚糖-阿拉伯胶胶囊,海藻酸钙-壳聚糖-阿拉伯胶胶囊为460-500μm。
实施例
实施例1
一种谷物冲调粉,其制备方法为:
S1.粉碎:将粒径大于60目的原料粉碎为60-80目;
S2.混料:将豌豆粉15kg、低聚异麦芽糖15.5kg、植脂末5kg、香蕉粉3kg、菊粉1kg、麦芽糊精1.5kg、乳酸菌粉0.7kg、柠檬酸0.012kg、香精0.008kg投入混料机进行混合,混合时间为20min。
S3.装包:将混合均匀的原料的按规格进行包装
实施例2
与实施例1不同的是,原料配比的不同,详见表1。
表1实施例1-5原料配比表
实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 | |
豌豆粉 | 15 | 16 | 18 | 20 | 25 |
低聚异麦芽糖 | 15.5 | 15.4 | 15.2 | 15.0 | 14.5 |
植脂末 | 5 | 8 | 10 | 15 | 20 |
香蕉粉 | 3.0 | 2.5 | 2.0 | 1.5 | 1.0 |
菊粉 | 1.0 | 2.0 | 3.0 | 4.0 | 5.0 |
麦芽糊精 | 1.5 | 1.2 | 1.0 | 0.8 | 0.5 |
乳酸菌粉 | 0.7 | 0.75 | 0.78 | 0.82 | 0.85 |
柠檬酸 | 0.012 | 0.011 | 0.010 | 0.009 | 0.008 |
香精 | 0.008 | 0.009 | 0.010 | 0.011 | 0.012 |
实施例6-7
与实施例3不同的是,步骤S2中,混合时间分别为15min、30min。
实施例8-12
与实施例7不同的是,原料中还分别包括0.3kg、0.4kg、0.5kg、0.2kg、0.6kg三丁酸甘油酯。
实施例13
与实施例9不同的是,用来自制备例1的海藻酸钙微胶囊替换乳酸菌粉,其中制备例1中乳酸菌粉的用量与实施例9相同。
实施例14
与实施例13不同的是,用来自制备例2的海藻酸钙-壳聚糖微胶囊替换乳酸菌。
实施例15-17
与实施例14不同的是,用来自制备例3-5的海藻酸钙-壳聚糖-阿拉伯胶微胶囊替换乳酸菌粉。
对比例
对比例1
与实施例3不同的是,用等量乳酸菌粉替换低聚异麦芽糖。
对比例2
与实施例3不同的是,用等量低聚异麦芽糖替换乳酸菌粉。
对比例3
与实施例3不同的是,用等量豌豆粉替换香蕉粉。
性能检测试验
检测方法
模拟肠液中益生菌的释放检测:
人工模拟胃液:用NaCl、胃蛋白酶配置人工模拟胃液,人工模拟胃液中NaCl浓度为9g/L、胃蛋白酶浓度为3g/L、pH值1.8。
人工模拟肠液:用KH2PO4、胰蛋白酶、胰凝乳蛋白酶配置人工模拟肠液,人工模拟肠液中KH2PO4浓度为6.8g/L、胰蛋白酶浓度为4.5g/L、胰凝乳蛋白酶浓度为1g/L、pH值6.5。
取100g实施例1-17与对比例1-3中的谷物冲调粉,置于3L人工模拟胃液中,37℃条件下消化2h,然后将分离人工模拟胃液,并将人工模拟胃液以外的其他物质置于2L人工模拟肠液中,37℃条件下消化1h、2h、3h后分别取样对人工模拟肠液内释放的益生菌进行平板菌落计数。检测结果见表2。
功能性检测:
选用食积气滞、腹胀便秘的志愿者各30人,每天食用谷物冲调粉,食用方法为:将5g谷物冲调粉加入25-40℃的水中搅拌均匀后饮用,7天为一个疗程,7天后统计志愿者食积气滞、腹胀便秘改善情况,并计算有效率,有效率=(症状改善人数/30)*100%。检测结果见表3。
表2人工模拟肠液中活菌数检测结果
表3功能性检测结果
结合实施例1-17和对比例1-3,并结合表2与表3可以看出,志愿者饮用实施例1-17制备的谷物冲调粉后,在缓解食积气滞、腹胀便秘等方面的有效率均优于对比例1-3,说明本申请制得的谷物冲调粉,在调节肠道菌群、助消化方面表现更优;另外,实施例1-17中谷物冲调粉在人工模拟肠液中1-3h释放的活菌数更高,这可能就是实施例1-17制得的谷物冲调粉在调节肠道菌群、助消化方面表现更优的原因。
结合实施例3与实施例1-2,并结合表2与表3可以看出,志愿者饮用实施例3制备的谷物冲调粉后,在缓解食积气滞、腹胀便秘等方面的有效率均优于对比例1-2,实施例3中谷物冲调粉在人工模拟肠液中1-3h释放的活菌数高于对比例1-2,而对比例1以及对比例2与实施例3的区别是乳酸菌粉、低聚异麦芽糖的添加情况的变化,这说明乳酸菌粉与低聚异麦芽糖复配作用,使得肠液中活菌数提高,从而使得谷物冲调粉在调节肠道菌群、助消化方面表现更优。
结合实施例3与实施例6-7,并结合表2与表3可以看出,制备无辜冲调粉时,原料在混料机中的混料时间对谷物冲调粉的性能有一定的影响,混料时间大于等于20min,制得的谷物冲调粉在在调节肠道菌群、助消化方面表现更优,而实施例3与实施例7中谷物冲调粉人工模拟肠液中1-3h释放的活菌数相差不多,在考虑性能与效率的情况下,混料时间可以设置为20min。
结合实施例7与实施例8-12,并结合表2与表3可以看出,实施例8-12中谷物冲调粉人工模拟肠液中1-3h释放的活菌数明显高于实施例7,志愿者饮用实施例9制备的谷物冲调粉后,在缓解食积气滞、腹胀便秘等方面的有效率均优于实施例7,这可能是因为添加的三丁酸甘油酯与乳酸菌粉共同作用,提高了肠液中的有效活菌数,从而提高了谷物冲调粉在调节肠道菌群、助消化方面的表现效果。
结合实施例9与实施例13-15,并结合表2与表3可以看出,实施例13-15中谷物冲调粉人工模拟肠液中1-3h释放的活菌数明显高于实施例9,志愿者饮用实施例13-15制备的谷物冲调粉后,在缓解食积气滞、腹胀便秘等方面的有效率均优于实施例9;这可能是因为乳酸菌在高酸性的胃液中存活率较低,从而导致达到肠液处的活菌数降低,而将乳酸菌以微胶囊的形式添加,胶囊壁对乳酸菌有保护作用,降低乳酸菌经过胃液后的死亡率,到达肠液中后,胶囊中的乳酸菌释放,从而提高肠液中的有效活菌数,提高了谷物冲调粉在调节肠道菌群、助消化方面的表现效果。
结合实施例13-15,并结合表2与表3可以看出,在肠液中消化1h时,实施例13中的活菌数即达到实施例14与实施例15中消化3h的活菌数,而志愿者饮用实施例13-15制备的谷物冲调粉后,在缓解食积气滞、腹胀便秘等方面的有效率逐渐升高,这可能是因为二层、三层胶囊壁延缓了胶囊的崩解时间,使得胶囊中乳酸菌在肠道内缓慢释放,有助于微胶囊中乳酸菌到达肠道远端,发挥其调节肠道菌群、助消化的作用。
本具体实施例仅仅是对本申请的解释,其并不是对本申请的限制,本领域技术人员在阅读完本说明书后可以根据需要对本实施例做出没有创造性贡献的修改,但只要在本申请的权利要求范围内都受到专利法的保护。
Claims (9)
1.一种谷物冲调粉,其特征在于:由包括以下重量份的原料制备而成:豌豆粉15-25份、低聚异麦芽糖14.5-15.5份、植脂末5-20份、香蕉粉1-3份、菊粉1-5份、麦芽糊精0.5-1.5份、乳酸菌粉0.7-0.85份、柠檬酸0.008-0.012份、香精0.008-0.012份。
2.根据权利要求1所述的一种谷物冲调粉,其特征在于:由包括以下重量份的原料制备而成:豌豆粉16-20份、低聚异麦芽糖15-15.4份、植脂末8-15份、香蕉粉1.5-2.5份、菊粉2-4份、麦芽糊精0.8-1.2份、乳酸菌粉0.75-0.82份、柠檬酸0.009-0.011份、香精0.009-0.011份。
3.根据权利要求1所述的一种谷物冲调粉,其特征在于:所述谷物冲调粉还包括重量份为0.3-0.5的三丁酸甘油酯。
4.根据权利要求1所述的一种谷物冲调粉,其特征在于:以所述乳酸菌粉为芯材,以海藻酸钙为壁材,制备海藻酸钙微胶囊,将乳酸菌粉以海藻酸钙微胶囊的形式添加。
5.根据权利要求4所述的一种谷物冲调粉,其特征在于:在所述海藻酸钙微胶囊外包裹壳聚糖,制备海藻酸钙-壳聚糖微胶囊,将乳酸菌粉以海藻酸钙-壳聚糖微胶囊的形式添加。
6.根据权利要求5所述的一种谷物冲调粉,其特征在于:在所述海藻酸钙-壳聚糖微胶囊包裹阿拉伯胶,制备海藻酸钙-壳聚糖-阿拉伯胶微胶囊,将乳酸菌粉以海藻酸钙-壳聚糖-阿拉伯胶微胶囊的形式添加。
7.根据权利要求6所述的一种谷物冲调粉,其特征在于:所述海藻酸钙-壳聚糖-阿拉伯胶微胶囊的粒径为400-450μm。
8.权利要求1-7任一所述一种谷物冲调粉的制备方法,其特征在于,包括以下步骤:
粉碎;将粒径大于60目的原料粉碎为60-80目;
混料:将原料按重量份混合均匀;
装包:将混合均匀的原料的按规格进行包装。
9.根据权利要求8所述一种谷物冲调粉的制备方法,其特征在于:混料时间大于等于20min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110965978.1A CN113925129A (zh) | 2021-08-23 | 2021-08-23 | 一种谷物冲调粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110965978.1A CN113925129A (zh) | 2021-08-23 | 2021-08-23 | 一种谷物冲调粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113925129A true CN113925129A (zh) | 2022-01-14 |
Family
ID=79274595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110965978.1A Pending CN113925129A (zh) | 2021-08-23 | 2021-08-23 | 一种谷物冲调粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113925129A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616656A (zh) * | 2003-11-10 | 2005-05-18 | 中国科学院大连化学物理研究所 | 一种固定化酵母细胞的微胶囊制备方法 |
CN1969889A (zh) * | 2006-12-04 | 2007-05-30 | 济南赛拜斯生物工程有限公司 | 肠溶性多层包被益生菌微胶囊及其制备方法 |
CN105454423A (zh) * | 2014-09-12 | 2016-04-06 | 杭州维力佳食品有限公司 | 香蕉味发酵型含乳饮料及其生产方法 |
CN106082408A (zh) * | 2016-07-01 | 2016-11-09 | 北京建筑大学 | 一种用于饮水机的茶多酚消毒颗粒的制备方法及消毒装置 |
CN109998011A (zh) * | 2019-05-20 | 2019-07-12 | 味利岛(上海)企业管理有限公司 | 谷物粉益生菌冲饮配方 |
US20200360418A1 (en) * | 2019-05-15 | 2020-11-19 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
CN113274369A (zh) * | 2021-04-29 | 2021-08-20 | 暨南大学 | 一种结肠靶向的口服益生菌微囊及其制备方法与应用 |
-
2021
- 2021-08-23 CN CN202110965978.1A patent/CN113925129A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616656A (zh) * | 2003-11-10 | 2005-05-18 | 中国科学院大连化学物理研究所 | 一种固定化酵母细胞的微胶囊制备方法 |
CN1969889A (zh) * | 2006-12-04 | 2007-05-30 | 济南赛拜斯生物工程有限公司 | 肠溶性多层包被益生菌微胶囊及其制备方法 |
CN105454423A (zh) * | 2014-09-12 | 2016-04-06 | 杭州维力佳食品有限公司 | 香蕉味发酵型含乳饮料及其生产方法 |
CN106082408A (zh) * | 2016-07-01 | 2016-11-09 | 北京建筑大学 | 一种用于饮水机的茶多酚消毒颗粒的制备方法及消毒装置 |
US20200360418A1 (en) * | 2019-05-15 | 2020-11-19 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
CN109998011A (zh) * | 2019-05-20 | 2019-07-12 | 味利岛(上海)企业管理有限公司 | 谷物粉益生菌冲饮配方 |
CN113274369A (zh) * | 2021-04-29 | 2021-08-20 | 暨南大学 | 一种结肠靶向的口服益生菌微囊及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110353144A (zh) | 一种益生菌固体饮料及其制备工艺 | |
US20010016220A1 (en) | Encapsulated multifunctional biologically active food component, process for its production and its use | |
CN111493322B (zh) | 一种微囊化益生菌及其制备方法和应用 | |
CN107164274B (zh) | 一种乳酸菌复合菌剂及其制备方法和应用 | |
CN106509439B (zh) | 替代抗生素预防断奶仔猪腹泻的饲料添加剂 | |
CN104172138B (zh) | 一种鸡腿菇咀嚼片的制备方法 | |
CN108904546A (zh) | 一种对幽门螺旋杆菌有抑制、杀灭作用的益生菌组合制剂及其制备方法 | |
CN106490360A (zh) | 一种猪用绿色饲料添加剂及其制备方法 | |
CN106819492A (zh) | 一种断奶仔猪用饲料添加剂 | |
CN107019211A (zh) | 制备具有补肾强肾功能的植物酵素的发酵组合物及制法 | |
CN108420025A (zh) | 灵武长枣泡菜及制作方法 | |
AU2007302899B2 (en) | Pre-fermented symbiotic matrix based on a cereal suspension with encapsulated probiotics, manufacture process and corresponding utilization | |
CN107594109A (zh) | 一种宠物饮用酵素液及其制备方法 | |
EP2031975A1 (en) | Method for embedding and targeted release of micronutrients in activated dietary fibers | |
CN111066991A (zh) | 一种改善胃肠道功能的复合益生元固体饮料的制备方法 | |
CN109588724A (zh) | 一种调理胃病的益生菌粉及其制备方法 | |
CN107535851B (zh) | 黑麦芽粉的制备方法及富含活性益生菌的黑麦芽粉的制备方法 | |
CN113925129A (zh) | 一种谷物冲调粉及其制备方法 | |
CN106070984A (zh) | 一种含益生元的软糖及其制备方法 | |
CN106070813A (zh) | 绿茶粉营养冲剂 | |
CN115919961B (zh) | 一种天佛参口服液及其制备方法和应用 | |
Tsen et al. | Banana puree fermentation by Lactobacillus acidophilus immobilized in Ca-alginate | |
CN108064941B (zh) | 一种百合莲子酸奶及其制备方法 | |
CN110897111A (zh) | 一种海藻酸钙冷工艺吸吸冻及其制备方法 | |
US20200368294A1 (en) | Thickening composition for dysphagia patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220114 |
|
RJ01 | Rejection of invention patent application after publication |